Expanding the Opportunities for Modulating Kinase Targets with Allosteric Approaches
The need for novel approaches for targeting well-known protein families in drug discovery has been discussed for several years. There is a huge amount of literature on the inhibition of kinases with small molecules targeting the ATP site, and as a result of this extensive research, there are a large number of kinase inhibitors in the clinic. However, even though the idea of targeting other sites on kinases is not new, relatively little has been reported. In this review we give an overview of structurally characterized allosteric kinase inhibitors, outline the benefits of these with the use of case studies and then discuss the challenges that need to be overcome and the opportunities for doing this..
| Media Type: |
Article |
|---|
| Year of Publication: |
2017 |
|---|---|
| Publication: |
2017 |
| Contained In: |
To Main Record - volume:17 |
|---|---|
| Contained In: |
Current topics in medicinal chemistry - 17(2017), 1, Seite 59-70 |
| Language: |
English |
|---|
| Contributors: |
Henrik Mobitz [Author] |
|---|
| Links: |
|---|
| BKL: |
|---|
| Supporting institution / Project title: |
|
|---|
| PPN (Catalogue-ID): |
OLC1989809804 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1989809804 | ||
| 003 | DE-627 | ||
| 005 | 20230515132331.0 | ||
| 007 | tu | ||
| 008 | 170207s2017 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a PQ20170206 |
| 035 | |a (DE-627)OLC1989809804 | ||
| 035 | |a (DE-599)GBVOLC1989809804 | ||
| 035 | |a (PRQ)b1533-e14434235800a3a029b6251bb807a977baef36e185e058c88887f6ffe62cf3560 | ||
| 035 | |a (KEY)0446467220170000017000100059expandingtheopportunitiesformodulatingkinasetarget | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 540 |q DNB |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 0 | |a Henrik Mobitz |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Expanding the Opportunities for Modulating Kinase Targets with Allosteric Approaches |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a The need for novel approaches for targeting well-known protein families in drug discovery has been discussed for several years. There is a huge amount of literature on the inhibition of kinases with small molecules targeting the ATP site, and as a result of this extensive research, there are a large number of kinase inhibitors in the clinic. However, even though the idea of targeting other sites on kinases is not new, relatively little has been reported. In this review we give an overview of structurally characterized allosteric kinase inhibitors, outline the benefits of these with the use of case studies and then discuss the challenges that need to be overcome and the opportunities for doing this. | ||
| 700 | 0 | |a Wolfgang Jahnke |4 oth | |
| 700 | 0 | |a Sandra W. Cowan-Jacob |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Current topics in medicinal chemistry |d Hilversum [u.a.] : Bentham Science Publ., 2001 |g 17(2017), 1, Seite 59-70 |w (DE-627)338770283 |w (DE-600)2064823-6 |w (DE-576)435515160 |x 1568-0266 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2017 |g number:1 |g pages:59-70 |
| 856 | 4 | 2 | |u http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1568-0266&volume=17&issue=1&spage=59 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 936 | u | w | |d 17 |j 2017 |e 1 |h 59-70 |
| 951 | |a AR | ||
| 952 | |d 17 |j 2017 |e 1 |h 59-70 | ||